Author Archive: Abigail Hirsch

Abigail Hirsch

Abigail is the Director of Events Communications at BIO. Although she has lived in the Washington, DC, area for nearly eight years, she still considers Virginia Beach home, especially with her parents and closest friends still in the area. According to Abigail, there is nothing better than sitting on the beach with a good book and cold drink. In her spare time, she enjoys visiting antique stores, finishing her twin sister Brooke’s sentences and spending time with her two boys, Frank her English bulldog, and JP her soon-to-be husband. Check back often for updates, Abigail’s take on BIO related events, and much more. And please, be kind, this is her first venture in to the blogging world!

Latest Posts

2012 Biotech Humanitarian Award Nominations Open

offit-btn

BIO is now accepting nominations for the fourth annual Biotech Humanitarian Award. The Award will be given to an individual who, through their work in or support of biotechnology, is harnessing its potential to heal, fuel or feed the planet. The Humanitarian Award honors work that aims to reduce human suffering significantly or enhance the human experience in a way that has a clear and direct benefit to society.  Additional consideration will be given to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

2012 BIO International Convention Show Daily – Submissions Now Accepted!

BIOSHOW_TUES-FINAL_cover_small

Looking to gain exposure for your company at Convention? Why not submit an article to be considered for the BIOtechNow Show Daily? The BIOtechNow Show Daily is an on-site publication that gets distributed Monday through Thursday at the 2012 BIO International Convention. The daily is distributed in high traffic areas of the Boston Convention & Exhibition Center as well as major hotel lobbies. This “must read” will contain all the hottest breaking news from Convention, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

Industry Outlook in Anticipation of the 2012 BIO International Convention

HC5O7460

This month, BIO wrapped the 14th Annual CEO & Investor Conference in New York City at the Waldorf=Astoria. Hosted by BIO, the event drew more than 1,200 industry leaders, featured 140 company presentations and a record breaking 1,300+ one-on-one meetings between 225 companies. Taking the momentum from this meeting, we now look ahead to the 2012 BIO International Convention to be held June 18 – 21, 2012 at the Boston Convention & Exhibition Center in Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Value Drivers Under the Influence – How Licensing and Key Events Affect Valuation

Stock Ticker

The Tuesday plenary luncheon at the 2012 BIO CEO & Investor Conference featured a panel of experts representing several perspectives on valuation. The session opened with Ben Bonifant, Senior Vice President & Practice Area Leader at Campbell Alliance, presenting results from their Corporate Value Study, which was followed by a discussion examining the key value drivers for emerging companies. Bonifant moderated the panel discussion that featured: Rachel K. King, Chief Executive Officer, GlycoMimetics, Inc. Michael Margolis, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Fireside Chat with Dr. Mikael Dolsten

Dolsten

Day two of the BIO CEO & Investor Conference kicked off with a Fireside Chat featuring Mikael Dolsten, MD, Phd, president, worldwide research & development from Pfizer, Inc and moderated by Mark Schoenebaum, senior biotechnology analyst with ISI Group. Speaking to a full room, Dr. Dolsten touched on Pfizer’s R&D priorities and their increased efforts to focus on investor capital return through a strong mixture of science, business and financial endeavors. In focusing on R&D, Pfizer has Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,